Biomedical Engineering Reference
In-Depth Information
64. Rondelli D, Barosi G, Bacigalupo A et al (2005) Allogeneic hematopoietic stem cell trasplan-
tation with reduced intensity conditioning in intermediate-or high risk patients with
myelofibrosis and myeloid metaplasia. Blood 105:4115-4119
65. Sureda A (2008) HSCT for Hodgkin's lymphoma in adults. In: Apperly J, Carreras E, Gluckman
E, Gratwohl A, Maszi T (eds) Haematopoietic stem cell transplantation. The EBMT handbook,
5th edn. ESH, Paris, pp 444-463
66. Sureda A, Robinson S, Canals C, Carella AM, Boogaerts MA, Caballero D et al (2008)
Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplanta-
tion in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working
Party of the European Group for blood and marrow transplantation. J Clin Oncol
26(3):455-462
67. Vose JM, Zhang MJ, Rowlings PA, Lazarus HM, Bolwell BJ, Freytes CO et al (2001)
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never
achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
Blood and marrow Transplant Registry. J Clin Oncol 19:406-413
68. Lazarus HM, Zhang MJ, Carreras J, Hayes-Lattin BM, Ataergin AS, Bitran JD et al (2010) A
comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse
large B cell lymphoma: a report from the CIBMTR. Biol Blood Marrow Transplant
16(1):35-45
69. Solal-Céligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R et al (2004)
Follicular lymphoma international prognostic index. Blood 104:1258-1265
70. Gribben JG (2008) HSCT for low-grade non-Hodgkin's lymphoma in adults. In: Apperly J,
Carreras E, Gluckman E, Gratwohl A, Maszi T (eds) Haematopoietic stem cell transplantation.
The EBMT handbook, 5th edn. ESH, Paris, pp 442-453
71. Blade J, Rosiñol L, Sureda A, Ribera JM, Díaz-Mediavilla J, García-Laraña J et al (2005)
High-dose therapy intensification compared with continued standard chemotherapy in multi-
ple myeloma patients responding to the initial chemotherapy: long-term results from a pro-
spective randomized trial from the Spanish cooperative group PETHEMA. Blood
106:3755-3759
72. Koreth J, Cutler CS, Djulbegovic B et al (2007) High dose therapy with single autologous
transplantation versus chemotherapy for newly diagnosed multiple myeloma. A systemic reb-
view and meta analysis of randomised controlled trials. Biol Blood Marrow Transplant
13:183-196
73. Young N, Calado RT, Scheinberg P (2006) Current concepts in the pathophysiology and treat-
ment of aplastic anemia. Blood 108:2509-2519
74. Champlin RE, Perez WS, Passweg JR, Klein JP, Camitta BM, Gluckman E et al (2007) Bone
marrow transplantation for severe aplastic anemia: a randomized controlled study of condi-
tioning regimens. Blood 109(10):4582-4585
75. Bacigalupo A, Piaggio G, Podesta M, Van Lint MT, Valbonesi M, Lercari G et al (1993)
Collection of peripheral blood hematopoietic progenitors (PBHP) from patients with severe
aplastic anemia (SAA) after prolonged administration of granulocyte colony-stimulating fac-
tor. Blood 82:1410-1414
